| scholarly article | Q13442814 |
| P356 | DOI | 10.3748/WJG.V8.I5.822 |
| P8608 | Fatcat ID | release_3msch7zfkjchlmxxbrwwpio6wm |
| P932 | PMC publication ID | 4656568 |
| P698 | PubMed publication ID | 12378623 |
| P5875 | ResearchGate publication ID | 291101279 |
| P2093 | author name string | Mei Wang | |
| Zhao-Shan Niu | |||
| Bo-Kian Li | |||
| P2860 | cites work | The p53 pathway | Q33643359 |
| Gene expression patterns in human liver cancers | Q33898932 | ||
| Review of 336 patients with hepatocellular carcinoma at Songklanagarind Hospital | Q34511976 | ||
| Hepatocellular carcinoma--cause, treatment and metastasis | Q34512068 | ||
| The prognostic molecular markers in hepatocellular carcinoma | Q34668320 | ||
| P53 immunohistochemical scoring: an independent prognostic marker for patients after hepatocellular carcinoma resection | Q36308536 | ||
| Methylation status of c-fms oncogene in HCC and its relationship with clinical pathology. | Q36397298 | ||
| Effect of phosphorylation of MAPK and Stat3 and expression of c-fos and c-jun proteins on hepatocarcinogenesis and their clinical significance. | Q36397319 | ||
| Alterations in metastatic properties of hepatocellular carcinoma cell following H-ras oncogene transfection | Q36397376 | ||
| Function of apoptosis and expression of the proteins Bcl-2, p53 and C-myc in the development of gastric cancer. | Q36397433 | ||
| Analysis of in vivo patterns of caspase 3 gene expression in primary hepatocellular carcinoma and its relationship to p21(WAF1) expression and hepatic apoptosis | Q36397474 | ||
| Expression of regulating apoptosis gene and apoptosis index in primary liver cancer. | Q36397719 | ||
| Infrequent p53 gene mutation and expression of the cardia adenocarcinomas from a high-incidence area of Southwest China | Q36397737 | ||
| Susceptibility to hepatocellular carcinoma associated with null genotypes of GSTM1 and GSTT1. | Q36491896 | ||
| Expression of insulin like growth factor II and its receptor in hepatocellular carcinogenesis. | Q36491997 | ||
| Expression of IGF- II, p53, p21 and HBxAg in precancerous events of hepatocarcinogenesis induced by AFB1 and/or HBV in tree shrews. | Q36492118 | ||
| Effects of endotoxin on expression of ras, p53 and bcl-2 oncoprotein in hepatocarcinogenesis induced by thioacetamide in rats | Q36724502 | ||
| Amplification of c-myc in hepatocellular carcinoma: correlation with clinicopathologic features, proliferative activity and p53 overexpression | Q38467523 | ||
| The p53 tumour suppressor gene | Q38548852 | ||
| The role of the p53 protein in the apoptotic response. | Q40585934 | ||
| Expression of c-Myc, c-Fos, and c-jun in hepatocellular carcinoma | Q40730809 | ||
| Immunohistochemical study on p53, H-rasp21, c-erbB-2 protein and PCNA expression in HCC tissues of Han and minority ethnic patients | Q41902323 | ||
| Effect of HCV infection on expression of several cancer-associated gene products in HCC. | Q41929746 | ||
| Expression of c-myc gene in human hepatoma | Q41982750 | ||
| Characterization of six tumor suppressor genes and microsatellite instability in hepatocellular carcinoma in southern African blacks | Q42021790 | ||
| Differentially expressed genes in hepatocellular carcinoma induced by woodchuck hepatitis B virus in mice. | Q43119119 | ||
| The significance of p53 mutations as an indicator of the biological behavior of recurrent hepatocellular carcinomas | Q44801395 | ||
| HBV status and expression of ets-2, IGF-II, C-myc and N-ras in human hepatocellular carcinoma and adjacent nontumorous tissues--a comparative study | Q44986578 | ||
| p53 gene mutation in hepatocellular carcinoma | Q45234400 | ||
| p53 gene mutation spectrum in hepatocellular carcinomas in Hong Kong Chinese. | Q46594117 | ||
| [Correlation between hypomethylation of c-myc and c-N-ras oncogenes and pathological changes in human hepatocellular carcinoma] | Q54263275 | ||
| Expression of c-myc gene product in gastric carcinoma | Q68203393 | ||
| Expression of cellular oncogenes in human primary liver cell carcinoma | Q68474289 | ||
| Expression of H-ras and c-myc protooncogenes in isolated gamma-glutamyl transpeptidase-positive rat hepatocytes and in hepatocellular carcinomas induced by diethylnitrosamine | Q69879966 | ||
| [Overexpression of c-myc and p53 gene in human hepato-cellular carcinoma--a study with immunohistochemistry and in situ hybridization] | Q71234509 | ||
| Overexpression of p53 in hepatocellular carcinomas: a clinicopathological and prognostic correlation | Q71717526 | ||
| Expression of apoptosis, proliferating cell nuclear antigen, and apoptosis-related antigens (bcl-2, c-myc, Fas, Lewis(y) and p53) in human cholangiocarcinomas and hepatocellular carcinomas | Q71774183 | ||
| [c-myc gene and p53 protein expression in human primary liver carcinoma] | Q72179097 | ||
| [The expression of C-myc, N-ras mRNA and its relations to the differentiation of preneoplastic altered hepatocytes] | Q72562981 | ||
| p53 in tumour pathology: can we trust immunohistochemistry?--Revisited! | Q72730267 | ||
| Experience of 1000 patients who underwent hepatectomy for small hepatocellular carcinoma | Q73746406 | ||
| p53 mutation and overexpression in hepatocellular carcinoma and dysplastic nodules in the liver | Q74175529 | ||
| [Regulation of p53 and bcl-2 proteins to apoptosis and cell proliferation in liver cirrhosis and hepatocellular carcinoma] | Q74348271 | ||
| Close correlation between a p53 or hMSH2 gene mutation in the tumor and survival of hepatocellular carcinoma patients | Q74453489 | ||
| [Clinical significance of c-myc oncogene amplification in primary hepatocellular carcinoma by interphase fluorescence in situ hybridization] | Q77696531 | ||
| p53: The Challenge of Linking Basic Science and Patient Management | Q77941894 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 822-826 | |
| P577 | publication date | 2002-10-01 | |
| P1433 | published in | World Journal of Gastroenterology | Q15708885 |
| P1476 | title | Expression of p53 and C-myc genes and its clinical relevance in the hepatocellular carcinomatous and pericarcinomatous tissues | |
| P478 | volume | 8 |
| Q33384004 | 2-D DIGE profiling of hepatocellular carcinoma tissues identified isoforms of far upstream binding protein (FUBP) as novel candidates in liver carcinogenesis |
| Q36496307 | Antisense oligonucleotide targeting at the initiator of hTERT arrests growth of hepatoma cells |
| Q36178628 | Codon 249 mutation in exon 7 of p53 gene in plasma DNA: maybe a new early diagnostic marker of hepatocellular carcinoma in Qidong risk area, China |
| Q38883226 | Combined use of nuclear phosphoprotein c-Myc and cellular phosphoprotein p53 for hepatocellular carcinoma detection in high-risk chronic hepatitis C patients |
| Q30921046 | Effect of arsenic trioxide on rat hepatocarcinoma and its renal cytotoxicity |
| Q36308149 | Effect of c-myc, Ki-67, MMP-2 and VEGF expression on prognosis of hepatocellular carcinoma patients undergoing tumor resection |
| Q53288154 | Folic acid supplementation during early hepatocarcinogenesis: cellular and molecular effects. |
| Q36190740 | Maxizyme-mediated specific inhibition on mutant-type p53 in vitro |
| Q40640641 | PPARgamma pathway activation results in apoptosis and COX-2 inhibition in HepG2 cells |
| Q41905030 | Peroxisome proliferator-activated receptor gamma ligands inhibit cell growth and induce apoptosis in human liver cancer BEL-7402 cells |
| Q36093388 | Phosphoinositide-3-kinase, catalytic, alpha polypeptide RNA interference inhibits growth of colon cancer cell SW948. |
| Q40030364 | ShRNA-mediated gene silencing of beta-catenin inhibits growth of human colon cancer cells |
| Q36178315 | Study on the mechanism of epidermal growth factor-induced proliferation of hepatoma cells |
| Q54435976 | The prevalence of the mutation in codon 249 of the P53 gene in patients with hepatocellular carcinoma (HCC) in Turkey. |
Search more.